FIELD: medicine.
SUBSTANCE: prevention of carcinogenic action of diethyl nitrosamine in experimental animals is ensured by introduction of kaskorutol dosed 0.4 g/kg within 9 months as an anticarcinogen, while diethyl nitrosamine is introduced in a dose 100 mg/l 5 days after introduction of kaskorutol within 4 months.
EFFECT: reduced carcinogenic action of diethyl nitrosamine due to inhibition of blastomogenic process, lowered level of lipid peroxidation, improved activity of antioxidant enzymes.
2 tbl, 8 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTION OF CARCINOGENIC ACTION OF DIETHYLNITROSAMINE IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2358747C1 |
| METHOD OF PREVENTING CARCINOGENIC EFFECT OF DIETHYLNITROSAMINE IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2363456C1 |
| METHOD FOR PREVENTION OF CANCEROGENIC EFFECT OF DIETHYLNITROSAMINE IN EXPERIMENTAL ANIMALS | 2014 |
|
RU2568587C2 |
| RHODANINE DERIVATIVE AND AGENT FOR PREVENTING MALIGNANT DISEASES | 2013 |
|
RU2521390C1 |
| SUBSTANCE SHOWING ANTICARCINOGENIC EFFECT IN GASTROINTESTINAL TRACT CARCINOGENESIS - "VITAMIN V" | 0 |
|
SU1796184A1 |
| METHOD FOR TREATING POSTOPERATIVE COMPLICATIONS | 2001 |
|
RU2199337C1 |
| METHOD FOR PREVENTION OF CANCEROGENIC ACTION OF METHYLNITROSOUREA IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410093C1 |
| METHOD OF PREVENTING CANCEROGENIC ACTION OF METHYLNITROSOUREA IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410114C1 |
| METHOD OF TREATING PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE | 2011 |
|
RU2472542C1 |
| PREPARATION BEING OF LIPID-CORRECTING, HYPOCOAGULATIVE AND ANTIOXIDANT PROPERTIES | 2005 |
|
RU2302248C2 |
